Close Menu

More articles about Informatics

Centogene said it will use the funds to accelerate growth and expansion in the areas of genetic testing, pharmaceutical collaborations, and big-data solutions.

The addition of the patient-facing family history platform will expand and enhance Invitae's existing genome management support services, the company said.

The partners have formed a public/private partnership to foster collaboration and data integration between different institutes researching brain trauma.

Diagnostic decision support company Variantyx is betting that clinicians need help sorting through NGS data and that the trend is toward whole-genome sequencing.

The system being developed would enable clinical decision-making based on genetic information about cancer cells and will leverage Fronteo's AI engine called KIBIT.

The new algorithm, called TOPSPIN, complements the company's MMprofiler test. It is considering making TOPSPIN-generated data available to its MMprofiler patients.

The companies aim to offer an end-to-end oncology genomic testing and clinical interpretation service for clinical laboratory customers.

The firm, which is the target of several lawsuits connected with its IPO, said 452 GPS Cancer Tests were ordered during the quarter. 

The blood-based test will use a 23-gene expression signature identified by researchers at VIB-KU Leuven and their collaborators.

The workgroup's goal is to encourage clinical labs to adopt uniform standards, so that clinical NGS test results can be compared among laboratories. 

The deal will join Fabric's genome annotation technology with Veritas' myGenome personal whole-genome sequencing service.

The firm said that its metagenomic sequencing-based service provides a broad scope of pathogen testing for people with chronic medical conditions.

The Israeli startup is establishing a global digital marketplace to facilitate genetic testing services.

GenePeeks will provide its Virtual Progeny Analytics approach, which includes scores that predict gene function and associated disease risk in hypothetical babies.

The system allows oncologists to pick treatment regimens using NantHealth's decision support tool, and order them directly through Allscript's EHR system.

Congenica will use the proceeds to establish its presence in the US and China, where it will court not only clinical genetics labs, but specialists, academics, biotech, and pharma.

The company will use the proceeds from the round to invest in sales and marketing efforts for its Sapientia clinical genome analysis platform, as well as for R&D.

The company offers what it calls an "end-to-end solution" for assembling study cohorts, tackling a challenging part of the diagnostic development process.

Illumina said the registration for its analysis software is the first step toward launching a full CE-IVD VeriSeq NIPT assay in Europe.

As SpeeDx preps for the European launch of its STI tests, it will incorporate UgenTec's automated data analysis tool for PCR applications.

Pages